Applied Proteomics

Applied Proteomics

Based: San Diego
Raised: $22.5 million
Investors: Domain Associates and Vulcan Capital

The scoop: Applied Proteomics got 2012 off to a stylish start, raising fresh cash, moving from Glendale to San Diego and bringing in a new CEO, Peter Klemm, the former CEO of Lexington, MA-based Predictive Biosciences. The diagnostic test manufacturer was also planning some new hires in the new year.

Applied Proteomics
Read more on

Suggested Articles

Oncology is clearly a major medical and societal issue, but one that sees too much focus from biopharmas at the expense of other killers.

Durect’s share price fell 12% after half of the panel of painkiller experts recommended against approving Posimir.

China-based cancer and autoimmune disease biotech I-Mab Biopharma has raised $104 million on the U.S. Nasdaq composite.